Compare TRIP & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRIP | STAA |
|---|---|---|
| Founded | 2000 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2011 | 1995 |
| Metric | TRIP | STAA |
|---|---|---|
| Price | $8.93 | $20.78 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $14.40 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 3.5M | 737.1K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 675.00 | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $1,556,000,000.00 | $239,442,000.00 |
| Revenue This Year | $3.33 | $30.82 |
| Revenue Next Year | $5.12 | $8.41 |
| P/E Ratio | ★ N/A | $81.69 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.41 | $15.59 |
| 52 Week High | $19.45 | $35.87 |
| Indicator | TRIP | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 32.72 | 32.30 |
| Support Level | $8.41 | $19.82 |
| Resistance Level | $11.76 | $26.21 |
| Average True Range (ATR) | 0.35 | 1.01 |
| MACD | 0.09 | -0.16 |
| Stochastic Oscillator | 35.74 | 7.19 |
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025. The company is selling TheFork, its dining brand, which represented 12% of sales.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.